 |
|
|
| |
Week 48 results of the randomised, multicentre Maraviroc Switch study
(MARCH)
|
| |
| |
Reported by Jules Levin
EACS 2015 Oct 21-24 Barcelona, Spain - 15th European AIDS Conference
Sarah L. Pett1,2,3 on Behalf of the MARCH study group
1Kirby Institute, University of New South Wales, Sydney, Australia; 2MRC CTU at UCL, Institute of Clinical Trials and Methodology, and 3Clinical Research Group, Infection and Population Health, UCL, London, UK
|
| |
|
|
|
|
|
